4basebio PLC (LON:4BB - Get Free Report)'s share price rose 1.8% during mid-day trading on Monday . The stock traded as high as GBX 1,140 ($14.45) and last traded at GBX 1,140 ($14.45). Approximately 9 shares were traded during trading, a decline of 99% from the average daily volume of 845 shares. The stock had previously closed at GBX 1,120 ($14.19).
4basebio Stock Performance
The stock has a market cap of £141.42 million, a P/E ratio of -1,415.38 and a beta of 1.09. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. The firm's 50-day moving average price is GBX 1,186.80 and its 200-day moving average price is GBX 1,291.87.
4basebio Company Profile
(
Get Free Report)
4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
Read More
Before you consider 4basebio, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 4basebio wasn't on the list.
While 4basebio currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
